Caris Life Sciences Ratios (2024-2026) | CAI

Ratios Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter) 96.94%46.06%97.48%49.64%63.99%69.11%13.05%99.10%
EBT Margin (Quarter) -66.15%-66.65%-28.44%-84.84%-39.58%11.22%27.98%-0.30%
EBIT Margin (Quarter) -66.98%-59.87%-28.52%-47.93%-9.92%15.05%30.19%2.44%
EBITDA Margin (Quarter) -66.98%-59.87%-28.52%-47.93%-9.92%15.05%30.19%2.44%
Operating Margin (Quarter) -66.98%-59.87%-28.52%-47.93%-9.92%15.05%30.19%2.44%
Net Margin (Quarter) -89.74%-90.92%-47.68%-105.07%-285.12%11.22%27.98%-0.24%
FCF Margin (Quarter) -64.22%-36.34%-25.89%1.75%25.52%19.12%15.28%
Efficiency
Inventory Average (Quarter) 44.96M56.46M69.96M
Assets Average (Quarter) 969.81M1,055.12M1,144.03M
Invested Capital (Quarter) 60.09M0.10M0.16M0.17M0.17M
Asset Utilization Ratio (Quarter) 0.670.770.79
Leverage & Solvency
Interest Coverage Ratio (Quarter) -4.90-4.411.45-4.53-0.050.07-44.720.41
Debt Ratio (Quarter) 1.260.390.380.340.33
Times Interest Earned (Quarter) -4.90-4.411.45-4.53-0.050.07-44.720.41
Valuation
Enterprise Value (Quarter) -67.64M-721.95M-757.01M-800.09M-823.46M
Return Ratios
Return on Sales (Quarter) -0.01%-0.01%0.00%-0.01%0.00%0.00%0.00%0.00%
Return on Capital Employed (Quarter) -9.09%4.86%10.83%
Return on Invested Capital (Quarter) 2.11%
Return on Assets (Quarter) 0.00%0.00%0.00%